Teladoc Health Inc buy The Goldman Sachs Group, Inc.
Start price
18.02.25
/
50%
€12.54
Target price
18.02.26
€15.31
Performance (%)
-40.41%
Price
14:49
€7.48
Summary
This prediction is currently active. Massive losses of -40.41% have been the result for the BUY prediction by The_Goldman_Sachs_Gr. This prediction currently runs until 18.02.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teladoc Health Inc | -8.450% | -8.450% |
| iShares Core DAX® | -0.998% | -2.096% |
| iShares Nasdaq 100 | 2.834% | 5.451% |
| iShares Nikkei 225® | 5.533% | 12.779% |
| iShares S&P 500 | 1.544% | 3.485% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Teladoc Health Inc diskutieren
Teladoc Health, Inc. (NYSE: TDOC) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $14.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for TDOC provided by MarketBeat